| 10991 |
16(R)-AFP 07 (free acid)
Exclusive |
|
773525-80-2 |
≥98%
|
|
✓ |
2011-08-16
|
52.354989752770
|
16-r-afp-07-free-acid
|
|
prostaglandins I2 PGI2 prostacyclin IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 PGs prostacyclin AFP-07 AFP07 EP prostanoids |
52.354989752770
|
| 14810 |
17-phenyl trinor Prostaglandin E2
|
|
38315-43-4 |
>98%
|
|
|
|
56.688241252302
|
17-phenyl-trinor-prostaglandin-e2
|
17-phenyl trinor PGE2
|
agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 |
56.688241252302
|
| 9000787 |
2-chloro Adenosine
|
|
40656-71-1 |
≥98%
|
|
|
2011-06-29
|
0.741560773480
|
2-chloro-adenosine
|
2-CADO; NSC 158900; 6-Amino-2-chloropurine riboside
|
adenosine receptors analogs agonists seizures neuroscience NSC158900 NSC-158900 neurotransmission A1 A2A A2B A3 G protein-coupled 2-chloroadenosine 2CA 2-CA 2 CA CADO |
0.741560773480
|
| 10437 |
3'4'-Methylenedioxy-α-pyrrolidinobutiophenone (hydrochloride)
New |
|
24622-60-4 |
≥97%
|
|
|
2011-08-23
|
58.115568815438
|
3-4-methylenedioxy-pyrrolidinobutiophenone-hydrochloride
|
MDPBP
|
designer drugs forensics sciences stimulants PPP MDPV cathinones narcotics pyrrolidinoprophenone methylenedioxpyrovalerone 784985-33-7 |
58.115568815438
|
| 10439 |
3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (hydrochloride)
Exclusive New |
|
24698-57-5 |
≥97%
|
|
✓ |
2011-08-24
|
42.097344748551
|
3-4-methylenedioxy-pyrrolidinopropiophenone-hydrochloride
|
MDPPP
|
designer drugs forensics sciences narcotics cathinones stimulants PPP MDPV Wistar rats methylenedioxypyrovalerone α-pyrrolidinopropiophenone 783241-66-7 |
42.097344748551
|
| 9000895 |
4-methoxy DMT
New |
|
3965-97-7 |
≥98%
|
|
|
2011-11-21
|
96.998213852581
|
4-methoxy-dmt
|
4-MeO DMT; 4-methoxy-N,N-Dimethyltryptamine
|
hallucinogen DMT dimethyltryptamine 5-HT receptors agonists 5-hydroxytryptamine behavior neuroscience forensics 4-OMe DMT 4 OMe DMT 4OMe DMT tryptamine |
96.998213852581
|
| 10449 |
4'-Methoxy-α-pyrrolidinopropiophenone (tosylate)
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-08-29
|
38.094499899571
|
4-methoxy-pyrrolidinopropiophenone-tosylate
|
MOPPP
|
analogs MDPV forensics sciences 478243-09-3 cathinones designer drugs |
38.094499899571
|
| 10448 |
4'-Methyl-α-pyrrolidinohexanophenone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2011-10-21
|
21.055398696870
|
4-methyl-pyrrolidinohexanophenone-hydrochloride
|
MPHP
|
34138-58-4 designer drugs forensics pyrovalerone bath salts MPPP PPP α-PPP α PPP psychostimulant toxic liver damage
rabdomyloysis |
21.055398696870
|
| 10446 |
4'-Methyl-α-pyrrolidinopropiophenone (hydrochloride)
Exclusive New |
|
1313393-58-6 |
≥97%
|
|
✓ |
2011-08-25
|
53.996528357980
|
4-methyl-pyrrolidinopropiophenone-hydrochloride
|
MPPP
|
designer drugs forensics pyrrolidinyl narcotics cathinones PPP metabolism stimulants MDMA receptors agonists analogs 28117-80-8 |
53.996528357980
|
| 13655 |
Adapalene
|
|
106685-40-9 |
≥98%
|
|
|
2010-09-10
|
4.705864463481
|
adapalene
|
Differin; CD 271
|
agonists retinoic acids differentiation anti-inflammatory inflammation antiinflammatory anti inflammatory RARs RAR-β RARβ β RAR-b RARb RARbeta RAR-beta RAR-.beta. RAR.beta. RAR-γ RARγ RARg RAR-g RARgamma RAR-gamma RAR.gamma. RAR-.gamma. CD-271 CD271 Naphthalenes |
4.705864463481
|
| 13626 |
AFP 07 (free acid)
Exclusive New |
|
788799-13-3 |
≥98%
|
|
✓ |
2011-08-31
|
9.319906478595
|
afp-07-free-acid
|
|
prostaglandins I2 PGI2 PGs prostacyclins IP receptors agonists EP1 EP2 EP3 EP4 AH 23848 AH-23848 prostanoids platelets vasodialation aggregation pulmonary vascular AH23848 AFP07 AFP-07 |
9.319906478595
|
| 13620 |
AL 6598
Exclusive |
|
170291-06-2 |
97%
|
|
✓ |
2010-09-16
|
48.491027624309
|
al-6598
|
|
intraocular pressures IOPs glaucoma PGD2 agonists DP receptors eyes hypertension F2 alpha Prostaglandin
Prostaglandin F2 alpha
F2alpha Prostaglandin
Prostaglandin F2alpha
9alpha,11beta-PGF2
9alpha,11beta PGF2
Prostaglandin F2
Enzaprost F alpha, PGF2 PGF2 alpha PGF2alpha Dinoprost Estrofan PGF2 |
48.491027624309
|
| 13452 |
AM3102
Exclusive |
|
213182-22-0 |
≥98%
|
|
✓ |
2009-08-11
|
45.108392879067
|
am3102
|
KDS-5104
|
OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic |
45.108392879067
|
| 13523 |
Apelin-13
|
|
217082-58-1 |
≥95%
|
|
|
2010-06-29
|
51.080481452249
|
apelin-13
|
|
ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine
Paracrine Protein Factors
Paracrine Peptide Factors
Growth Factors
|
51.080481452249
|
| 13524 |
Apelin-36
|
|
252642-12-9 |
≥95%
|
|
|
2011-04-04
|
55.485883977900
|
apelin-36
|
|
agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled |
55.485883977900
|
| 62170 |
Arachidonoyl Serinol
|
|
183718-70-9 |
>98%
|
|
|
|
32.943646408840
|
arachidonoyl-serinol
|
|
endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience cannabinoids cbs synthetic |
32.943646408840
|
| 10626 |
AS-1269574
Exclusive |
|
330981-72-1 |
≥98%
|
|
✓ |
2011-01-17
|
15.354143646409
|
as-1269574
|
|
diabetes glucose insulin receptors pancrease b-cells b cells .beta.-cells beta-cells β-cells β GPR119 GPR-119 GPR 119 lysophosphatidylcholine LPC oleoylethanol amides OEA agonist Ethanolamines Aminoethanols |
15.354143646409
|
| 10393 |
Butylone (hydrochloride)
New |
|
17762-90-2 |
≥97%
|
|
|
2011-08-17
|
63.857263276041
|
butylone-hydrochloride
|
β-keto MBDB
|
designer drugs forensics receptors agonists bath salts MBDB MDMA cathinone methylbenzodioxolylbutanamine methylenedioxymethamphetamine 802575-11-7 butylone |
63.857263276041
|
| 10012424 |
CAY10583
Exclusive |
|
862891-27-8 |
≥98%
|
|
✓ |
2009-07-21
|
63.267826887661
|
cay10583
|
|
LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation |
63.267826887661
|
| 13143 |
CAY10587
Exclusive |
|
1082058-99-8 |
≥98%
|
|
✓ |
2009-07-02
|
21.141132596685
|
cay10587
|
|
free fatty acid receptor1 FFA1 GPR40 pancreatic b-cells glucose insulin diabetes obesity metabolic syndrome receptors |
21.141132596685
|
| 13281 |
CAY10598
Exclusive |
|
346673-06-1 |
≥98%
|
|
✓ |
2010-05-07
|
73.670928176795
|
cay10598
|
|
Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection |
73.670928176795
|
| 13282 |
CAY10599
Exclusive |
|
1143573-33-4 |
≥98%
|
|
✓ |
2009-07-21
|
47.998624923265
|
cay10599
|
|
thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs |
47.998624923265
|
| 11015 |
Dexamethasone
New |
|
50-02-2 |
≥98%
|
|
|
2011-10-25
|
65.599524557757
|
dexamethasone
|
MK 125; NSC 34521
|
steroids hormones glucocorticoid agonist receptors inflammation genes expression anti-inflammatory antiinflammatory anti inflammatory 8054-59-9 137098-19-2 906362-70-7 906422-84-2 1050677-47-8 adexone aeroseb-Dex aphtasolon aphthasolone azium calonat corsone cortisumman decacort decaderm decadron A decalix decasone dekacort dekort delipos deltafluorene dergramin deronil desadrene desameton deseronil dexa-cortidelt dexa-mamallet dexa-scheroson dexa-sine dexacort dexacortal dexacortin dexadeltone dexafarma dexalona dexaltin dexameth dexamethasone alcohol dexamonozon dexapolcort dexapos dexaprol dexason dexasone dexinoral dexmethsone dexone dexonium dextelan dinomon diodex etacortilen fluormone fluorocort gammacorten gentalipos HL-dex hexadecadrol hexadrol isopto-dex lokalison F loverine luxazone MK-125 MK125 maxidex millicorten NSC-34521 NSC34521 oradexon pet-derm III posurdex prednisolon F prednisolone superprednol surodex visumetazone |
65.599524557757
|
| 13184 |
(±)-Equol
|
|
94105-90-5 |
≥98%
|
|
|
2009-09-03
|
4.849244935543
|
-equol
|
|
phytoestrogens estrogens daidzen genistein receptors cancers nonsteroidal ERα ERβ ERalpha ER.alpha. ERbeta ER.beta. breast cells proliferation 7,4'-homoisoflavone NV 07α 07alpha 66036-38-2 |
4.849244935543
|
| 10004236 |
Fluprostenol serinol amide
|
|
- |
≥98%
|
|
|
2004-09-23
|
25.495878453039
|
fluprostenol-serinol-amide
|
Flu-SA
|
PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 CBs synthetic |
25.495878453039
|
| 10851 |
Guanabenz (hydrochloride)
New |
|
- |
≥98%
|
|
|
2011-09-30
|
0.603038674033
|
guanabenz-hydrochloride
|
Wytensin
|
adrenergic receptors hypertension imidazoline adipose tissues neurosciences cardiovascular diseases agonists 5051-62-7 α2 alpha2 I2 hydrochloride HCl |
0.603038674033
|
| 13633 |
JWH 019
|
|
209414-08-4 |
≥98%
|
|
|
2010-01-14
|
50.127632658708
|
jwh-019
|
|
cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 |
50.127632658708
|
| 10979 |
MDMA methylene homolog (hydrochloride)
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-22
|
34.462629087627
|
mdma-methylene-homolog-hydrochloride
|
3,4-Methylenedioxymethamphetamine methyl homolog
|
forensic sciences cannabinoids CBs pyrovalerones pentylones designer drugs forensics neuroscience psychoactive ecstasy HCl |
34.462629087627
|
| 10749 |
Methylhexanamine (hydrochloride)
New |
|
13803-74-2 |
≥98%
|
|
|
2011-10-07
|
23.506575020663
|
methylhexanamine-hydrochloride
|
Forthane; NSC 1106; DMAA; Geranamine; Floradrene; Dimethylamylamine
|
stimulants designer drugs forensics sciences amphetamines amines nasal decongestant cerebral hemorrhage forthan methylhexaneamine 105-41-9 HCl allphatic floradrene |
23.506575020663
|
| 11151 |
Mitragynine
New |
|
4098-40-2 |
≥95%
|
|
|
2011-12-01
|
96.260735880908
|
mitragynine
|
9-methoxy Corynantheidine
|
alkaloids forensics Mitragyna pain neuroscience opioids receptors agonists incense indoles plants noradreneric serotonergic metabolites 11047-39-5 36455-45-5 1383-32-0 6202-22-8 |
96.260735880908
|
| 10517 |
Naphyrone (hydrochloride)
New |
|
850352-11-3 |
≥97%
|
|
|
2011-08-29
|
119.314385553262
|
naphyrone-hydrochloride
|
O-2482; NRG-1; Naphpyrovalerone; β-Naphyrone
|
analogs MDPV forensics sciences designer drugs 850352-53-3 pyrovalerones cathinones dopamine serotonins norepinephrines bath salts |
119.314385553262
|
| 11011 |
Pentedrone (hydrochloride)
Exclusive New |
|
879669-95-1 |
≥98%
|
|
✓ |
2011-08-23
|
85.426574239466
|
pentedrone-hydrochloride
|
α-methylamino-Valerophenone
|
analogs MDPV forensics sciences 879722-57-3 cathinones alkaloids psychotropics bath salts neurological HCl monoamine alkaloids methcathinone |
85.426574239466
|
| 10192 |
Prostaglandin D2 serinol amide
|
|
- |
>98%
|
|
|
2004-05-13
|
39.763292817680
|
prostaglandin-d2-serinol-amide
|
PGD2-SA
|
PGD2 vasodilation prostaglandins brain sleep platelets aggregation anandamides serinols amides cannabinoids AEA |
39.763292817680
|
| 10140 |
Prostaglandin E2-1-glyceryl ester
|
|
37497-47-5 |
>98% (as a 85:15 mixture of the 1- and 2-glyceryl esters)
|
|
|
|
48.040865561694
|
prostaglandin-e2-1-glyceryl-ester
|
PGE2-1-glyceryl ester
|
Prostaglandins PGE2-1-GE esters 2-AG 2-arachidonyl-glycerol metabolites COX-2 PGHS-2 cycloxygenases synthases PGE2-2-GE COX2 PGHS2 cannabinoids cbs synthetic |
48.040865561694
|
| 14012 |
Prostaglandin E2 Ethanolamide
Exclusive |
|
194935-38-1 |
>98%
|
|
✓ |
|
40.204841160221
|
prostaglandin-e2-ethanolamide
|
PGE2-EA; Dinoprostone Ethanolamide; Prostamide E2
|
anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides |
40.204841160221
|
| 10193 |
Prostaglandin E2 serinol amide
Exclusive |
|
- |
≥98%
|
|
✓ |
2004-03-03
|
36.258397790055
|
prostaglandin-e2-serinol-amide
|
PGE2-SA
|
PGE2SA cannabinoids agonists CB1 receptors analogs 2-glyceryl neurochemistry neuroscience |
36.258397790055
|
| 10194 |
Prostaglandin F2α serinol amide
|
|
- |
>98%
|
|
|
2004-02-23
|
13.622338858195
|
prostaglandin-f2-serinol-amide
|
PGF2α-SA
|
PGF2alphaSA PGF2.alpha.SA PGF2alpha-SA PGF2.alpha.-SA cannabinoids agonists CB1 recptors analogs 2-glyceryl esters amides neuroscience |
13.622338858195
|
| 10798 |
RCS-4-C4 homolog
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-04-21
|
58.428009777551
|
rcs-4-c4-homolog
|
BTM-4; SR-19; OBT-199; E-4
|
cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetics smoking urinary urine serum JWH018 JWH 018 JWH-018 JWH18 BTM4 BTM 4 E4 E 4 OBT199 OBT 199 SR19 SR 19 |
58.428009777551
|
| 10010172 |
(R)-Equol
Exclusive |
|
221054-79-1 |
≥98%
|
|
✓ |
2009-08-27
|
7.679378453039
|
-r-equol
|
Isoequol; (+)-Equol
|
phytoestrogens estrogens daidzen genistein receptors cancers R-Equol +equol + equol agonist activity R equol (R) equol |
7.679378453039
|
| 11017 |
Retinoic Acid
New |
|
302-79-4 |
≥98%
|
|
|
2011-10-25
|
11.043295402707
|
retinoic-acid
|
ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578
|
ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans |
11.043295402707
|
| 10010173 |
(S)-Equol
|
|
531-95-3 |
≥98%
|
|
|
2009-08-27
|
11.167541436464
|
-s-equol
|
4',7-Isoflavandiol; 4',7-Dihydroxyisoflavan; (-)-Equol
|
phytoestrogen estrogens daidzen genistein receptors cancers (S) equol S-equol -Equol (-) Equol antagonist |
11.167541436464
|
| 10683 |
SR 16584
New |
|
1150153-86-8 |
≥95%
|
|
|
2011-11-17
|
47.778732351136
|
sr-16584
|
|
antagonists receptors nicotinic acetylcholine receptors neuroscience nAChRs ligands ion channels central peripheral nerves nervous system subtypes SR-16584 SR16584 α3β4 α4β2 α7 |
47.778732351136
|
| 13830 |
Synthetic Cannabinoid HPLC Mixture I
|
|
- |
≥95% for each compound
|
|
|
2010-05-13
|
39.243082614455
|
synthetic-cannabinoid-hplc-mixture-i
|
|
cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic |
39.243082614455
|
| 13850 |
Synthetic Cannabinoid HPLC Mixture II
|
|
- |
≥95% for each compound
|
|
|
2010-12-21
|
39.551017802333
|
synthetic-cannabinoid-hplc-mixture-ii
|
|
cannabinoids CBs synthetics mixtures receptors agonists synthetic |
39.551017802333
|
| 11337 |
Synthetic Cannabinoid HPLC Mixture V (AM Series)
New |
|
- |
≥95% for each compound
|
|
|
2012-02-02
|
101.640890116636
|
synthetic-cannabinoid-hplc-mixture-v-am-series
|
|
AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 |
101.640890116636
|
| 10790 |
Xanomeline oxalate
|
|
141064-23-5 |
≥98%
|
|
|
2011-06-14
|
0.382872928177
|
xanomeline-oxalate
|
Lumeron; Memcor; LY246708
|
agonists muscarinic receptors acetylcholine psychosis antipsychotic memory neurotransmitters neurological Alzheimer’s diseases M1-preferring |
0.382872928177
|
| 13673 |
ZK118182 isopropyl ester
Exclusive |
|
154927-31-8 |
≥98%
|
|
✓ |
2010-11-05
|
0E-12
|
zk118182-isopropyl-ester
|
|
intraocular pressure IOP glaucoma PGD2 agonists DP receptors hypertension Hexadecanoylcarnitine
Palmitoylcarnitine
Palmitylcarnitine |
0E-12
|
| 10445 |
α-Pyrrolidinopropiophenone (hydrochloride)
Exclusive New |
|
92040-10-3 |
≥97%
|
|
✓ |
2011-08-24
|
45.101250382089
|
-pyrrolidinopropiophenone-hydrochloride
|
ɑ-PPP
|
designer drugs forensics analogs diethylcathinone Wistar rats cathinone appetite suppressants PPP MPPP MDPPP αPPP alphaPPP alpha-pyrrolidinopropiophenone 19134-50-0 |
45.101250382089
|